Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

View original content:https://www.prnewswire.co.uk/news-releases/henlius-and-dr-reddys-ink-licensing-deal-for-hlx15-investigational-daratumumab-biosimilar-expansion-in-europe-and-the-us-302370087.html View original content: https://www.prnewswire.co.uk/news-releases/henlius-and-dr-reddys-ink-licensing-deal-for-hlx15-investigational-daratumumab-biosimilar-expansion-in-europe-and-the-us-302370087.html

SHANGHAI, 06/02/2025 (informazione.news - comunicati stampa - salute e benessere)

View original content:https://www.prnewswire.co.uk/news-releases/henlius-and-dr-reddys-ink-licensing-deal-for-hlx15-investigational-daratumumab-biosimilar-expansion-in-europe-and-the-us-302370087.html